Biocon Limited in 1 story
The narratives BIOCON.NS currently appears in, with its side and exposure in each.
Bull side
1 story- America Imports the World's Drug Prices
BIOCON.NS in “America Imports the World's Drug Prices”
StableExposure: not rated yetUS reference pricing puts global blockbuster economics—and not just American list prices—under pressure.
Biocon's biosimilars platform targets expensive biologic categories where governments and payers need credible lower-cost competition.
Bear side
0 storiesNo bear-side stories for BIOCON.NS yet.